"Opioid Peptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way.
| Descriptor ID |
D018847
|
| MeSH Number(s) |
D12.644.400.575 D12.776.631.650.575
|
| Concept/Terms |
Opioid Peptides- Opioid Peptides
- Peptides, Opioid
- Opiate Peptides
- Peptides, Opiate
- Opioid Peptide
- Peptide, Opioid
|
Below are MeSH descriptors whose meaning is more general than "Opioid Peptides".
Below are MeSH descriptors whose meaning is more specific than "Opioid Peptides".
This graph shows the total number of publications written about "Opioid Peptides" by people in this website by year, and whether "Opioid Peptides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Opioid Peptides" by people in Profiles.
-
Parker KE, Pedersen CE, Gomez AM, Spangler SM, Walicki MC, Feng SY, Stewart SL, Otis JM, Al-Hasani R, McCall JG, Sakers K, Bhatti DL, Copits BA, Gereau RW, Jhou T, Kash TJ, Dougherty JD, Stuber GD, Bruchas MR. A Paranigral VTA Nociceptin Circuit that Constrains Motivation for Reward. Cell. 2019 07 25; 178(3):653-671.e19.
-
Beck TC, Reichel CM, Helke KL, Bhadsavle SS, Dix TA. Non-addictive orally-active kappa opioid agonists for the treatment of peripheral pain in rats. Eur J Pharmacol. 2019 Aug 05; 856:172396.
-
Taylor JJ, Borckardt JJ, George MS. Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain. 2012 Jun; 153(6):1219-1225.
-
Husain S, Abdul Y, Potter DE. Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des. 2012; 18(37):6101-8.
-
Wilson MA, Junor L. The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models. Neuropsychopharmacology. 2008 Nov; 33(12):2957-68.
-
McGinty JF. Co-localization of GABA with other neuroactive substances in the basal ganglia. Prog Brain Res. 2007; 160:273-84.
-
Wilson MA, Burghardt PR, Lugo JN, Primeaux SD, Wilson SP. Effect of amygdalar opioids on the anxiolytic properties of ethanol. Ann N Y Acad Sci. 2003 Apr; 985:472-5.
-
Abraham KE, McGinty JF, Brewer KL. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain. 2001 Feb 01; 90(1-2):181-90.
-
Abraham KE, McGinty JF, Brewer KL. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury. Neuroscience. 2001; 104(3):863-74.
-
Abraham KE, Brewer KL, McGinty JF. Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury. Neuroscience. 2000; 99(1):189-97.